These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10801994)

  • 1. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease.
    Santos RD; Sposito AC; Ventura LI; Cesar LA; Ramires JA; Maranhão RC
    Am J Cardiol; 2000 May; 85(10):1163-6. PubMed ID: 10801994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease.
    Spósito AC; Maranhão RC; Vinagre CG; Santos RD; Ramires JA
    Atherosclerosis; 2001 Feb; 154(2):455-61. PubMed ID: 11166779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of a chylomicron-like emulsion from plasma is delayed in patients with coronary artery disease.
    Martins MC; Pileggi F; Maranhão RC
    Braz J Med Biol Res; 1995 Apr; 28(4):427-31. PubMed ID: 8520539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease.
    Sposito AC; Santos RD; Hueb W; Ventura LI; Vinagre CC; Ramires JA; Maranhão RC
    Atherosclerosis; 2002 Apr; 161(2):447-53. PubMed ID: 11888530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
    Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
    J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of chylomicron-like lipid emulsions is increased in normal rabbits but not in heterozygous Watanabe heritable hyperlipidaemic rabbits following treatment with cholestyramine or pravastatin.
    Mamo JC; Bowler A; Redgrave TG; Elsegood CL
    Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):687-94. PubMed ID: 7820948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
    Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy.
    Aguilar-Salinas CA; Hugh P; Barrett R; Pulai J; Zhu XL; Schonfeld G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):72-82. PubMed ID: 9012640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins.
    Sposito AC; Santos RD; Amâncio RF; Ramires JA; Chapman MJ; Maranhão RC
    Atherosclerosis; 2003 Feb; 166(2):311-21. PubMed ID: 12535744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
    Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
    Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
    Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
    Oliveira MR; Maranhão RC
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1471-8. PubMed ID: 15486570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
    Gonçalves RP; Hungria VT; Chiattone CS; Pozzi DB; Maranhão RC
    Leuk Res; 2003 Feb; 27(2):147-53. PubMed ID: 12526920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
    Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
    J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cholesterol intake modifies chylomicron metabolism in normolipidemic young men.
    César TB; Oliveira MR; Mesquita CH; Maranhão RC
    J Nutr; 2006 Apr; 136(4):971-6. PubMed ID: 16549459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus.
    Lee SJ; Sacks FM
    Am J Cardiol; 2003 Jul; 92(2):121-4. PubMed ID: 12860210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm.
    Hosni JJ; Vinagre CG; Mady C; Maranhão RC
    Braz J Med Biol Res; 2007 Mar; 40(3):305-7. PubMed ID: 17334526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits.
    Mamo JC; Bowler A; Elsegood CL; Redgrave TG
    Biochim Biophys Acta; 1991 Feb; 1081(3):241-5. PubMed ID: 1998743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chylomicron metabolism in patients submitted to cardiac transplantation.
    Vinagre CG; Stolf NA; Bocchi E; Maranhão RC
    Transplantation; 2000 Feb; 69(4):532-7. PubMed ID: 10708107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.